Peripheral platelet count correlates with liver atrophy and predicts long-term mortality on the liver transplant waiting list

Transplant International

Volumn 26, Issue 4, 2013, Pages 435-442

  Bleibel, Wissam ^a,b   Caldwell, Stephen H ^b   Curry, Michael P ^a   Northup, Patrick G ^b  

^a HARVARD UNIVERSITY   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

body surface area; cirrhosis; computer tomography; liver volume; survival

Indexed keywords

ALBUMIN; BILIRUBIN; CREATININE;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CREATININE BLOOD LEVEL; END STAGE LIVER DISEASE; FEMALE; HOSPITAL ADMISSION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER ATROPHY; LIVER TRANSPLANTATION; LIVER WEIGHT; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; MODEL FOR END STAGE LIVER DISEASE; MORTALITY; PREDICTION; PRIORITY JOURNAL; SURVIVAL TIME; THROMBOCYTE COUNT; VIRUS HEPATITIS;

ADULT; AGED; ATROPHY; END STAGE LIVER DISEASE; FEMALE; HUMANS; LIVER; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; ORGAN SIZE; PLATELET COUNT; RETROSPECTIVE STUDIES; THROMBOPOIETIN; WAITING LISTS;

EID: 84875382268     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12064     Document Type: Article

References (40)

1. Alazawi W, Cunningham M, Dearden J, Foster GR,. Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection. Aliment Pharmacol Ther 2010; 32: 344.
2. Caldwell S, Argo C,. The natural history of non-alcoholic fatty liver disease. Dig Dis 2010; 28: 162.
3. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC,. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864.
4. Kamath PS, Wiesner RH, Malinchoc M, et al,. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464.
5. Wiesner R, Edwards E, Freeman R, et al,. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91.
6. Wiesner RH, McDiarmid SV, Kamath PS, et al,. MELD and PELD: application of survival models to liver allocation. Liver Transpl 2001; 7: 567.
7. Gotthardt D, Weiss KH, Baumgärtner M, et al,. Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation. BMC Gastroenterol 2009; 25: 72.
8. Cholongitas E, Papatheodoridis GV, Vangeli M, Terreni N, Patch D, Burroughs AK,. Systematic review: the model for end-stage liver disease-should it replace Child-Pugh's classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther 2005; 12: 1079.
9. Bambha KM, Biggins SW,. Inequities of the Model for End-Stage Liver Disease: an examination of current components and future additions. Curr Opin Organ Transplant 2008; 13: 227.
10. Cholongitas E, Marelli L, Kerry A, et al,. Different methods of creatinine measurement significantly affect MELD scores. Liver Transpl 2007; 13: 523.
11. Cholongitas E, Marelli L, Kerry A, et al,. Female liver transplant recipients with the same GFR as male recipients have lower MELD scores-a systematic bias. Am J Transplant 2007; 7: 685.
12. Arjal R, Trotter JF,. International normalized ratio of prothrombin time in the model for end-stage liver disease score: an unreliable measure. Clin Liver Dis 2009; 13: 67.
13. Schouten JN, Francque S, Van Vlierberghe H, et al,. The influence of laboratory-induced MELD score differences on liver allocation: more reality than myth. Clin Transplant 2012; 26: E62.
14. Lisman T, van Leeuwen Y, Adelmeijer J, et al,. Interlaboratory variability in assessment of the model of end-stage liver disease score. Liver Int 2008; 28: 1344.
15. Anstee QM, Dhar A, Thursz MR,. The role of hypercoagulability in liver fibrogenesis. Clin Res Hepatol Gastroenterol 2011; 35: 526.
16. Anstee QM, Wright M, Goldin R, Thursz MR,. Parenchymal extinction: coagulation and hepatic fibrogenesis. Clin Liver Dis 2009; 13: 117.
17. Kamel IR, Kruskal JB, Pomfret EA, Keogan MT, Warmbrand G, Raptopoulos V,. Impact of multidetector CT on donor selection and surgical planning before living adult right lobe liver transplantation. AJR Am J Roentgenol 2001; 176: 193.
18. Kamel IR, Kruskal JB, Warmbrand G, Goldberg SN, Pomfret EA, Raptopoulos V,. Accuracy of volumetric measurements after virtual right hepatectomy in potential donors undergoing living adult liver transplantation. AJR Am J Roentgenol 2001; 176: 483.
19. Heinemann A, Wischhusen F, Püschel K, Rogiers X,. Standard liver volume in the Caucasian population. Liver Transpl Surg 1999; 5: 366.
20. Du Bois D, Du Bois EF,. A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition 1989; 5: 303. discussion 312.
21. Giannini EG, Savarino V,. Thrombocytopenia in liver disease. Curr Opin Hematol 2008; 15: 473.
22. Shah SH, Hayes PC, Allan PL, Nicoll J, Finlayson ND,. Measurement of spleen size and its relation to hypersplenism and portal hemodynamics in portal hypertension due to hepatic cirrhosis. Am J Gastroenterol 1996; 91: 2580.
23. Sanyal AJ, Freedman AM, Purdum PP, Shiffman ML, Luketic VA,. The hematologic consequences of transjugular intrahepatic portosystemic shunts. Hepatology 1996; 23: 32.
24. Karasu Z, Gurakar A, Kerwin B, et al,. Effect of transjugular intrahepatic portosystemic shunt on thrombocytopenia associated with cirrhosis. Dig Dis Sci 2000; 45: 1971. Erratum in: Dig Dis Sci 2001 Feb;46(2):449.
25. Gschwantler M, Vavrik J, Gebauer A, et al,. Course of platelet counts in cirrhotic patients after implantation of a transjugular intrahepatic portosystemic shunt-a prospective, controlled study. J Hepatol 1999; 30: 254.
26. Jabbour N, Zajko A, Orons P, Irish W, Fung JJ, Selby RR,. Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis? Dig Dis Sci 1998; 43: 2459.
27. Akyüz F, Yekeler E, Kaymakoǧlu S, et al,. The role of thrombopoietin and spleen volume in thrombocytopenia of patients with noncirrhotic and cirrhotic portal hypertension. Turk J Gastroenterol 2007; 18: 95.
28. Pradella P, Bonetto S, Turchetto S, et al,. Platelet production and destruction in liver cirrhosis. J Hepatol 2011; 54: 894.
29. Broudy VC, Kaushansky K,. Biology of thrombopoietin. Curr Opin Pediatr 1998; 10: 60.
30. Rios R, Sangro B, Herrero I, Quiroga J, Prieto J,. The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis. Am J Gastroenterol 2005; 100: 1311.
31. El-Sayed R, El-Ela MA, El-Raziky MS, Helmy H, El-Ghaffar AA, El-Karaksy H,. Relation of serum levels of thrombopoietin to thrombocytopenia in extrahepatic portal vein obstruction versus cirrhotic children. J Pediatr Hematol Oncol 2011; 33: e267.
32. Martin TG 3rd, Somberg KA, Meng YG, et al,. Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation. Ann Intern Med 1997; 127: 285.
33. Peck-Radosavljevic M, Zacherl J, Wichlas M, et al,. Thrombopoietic cytokines and reversal of thrombocytopenia after liver transplantation. Eur J Gastroenterol Hepatol 1999; 11: 151.
34. Borel Rinkes IH, Van der Hoop AG, Hesselink EJ, et al,. Does auxiliary heterotopic liver transplantation reverse hypersplenism and portal hypertension? Gastroenterology 1991; 100: 1126.
35. Peck-Radosavljevic M, Wichlas M, Zacherl J, et al,. Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production. Blood 2000; 95: 795.
36. McCaughan GW, Herkes R, Powers B, et al,. Thrombocytopenia post liver transplantation. Correlations with pre-operative platelet count, blood transfusion requirements, allograft function and outcome. J Hepatol 1992; 16: 16.
37. McCaughan GW, Huynh JC, Feller R, Painter D, Waugh R, Sheil AG,. Fulminant hepatic failure post liver transplantation: clinical syndromes, correlations and outcomes. Transpl Int 1995; 8: 20.
38. Zhou XP, Lu T, Wei YG, Chen XZ,. Liver volume variation in patients with virus-induced cirrhosis: findings on MDCT. AJR Am J Roentgenol 2007; 189: W153.
39. Schiano TD, Bodian C, Schwartz ME, Glajchen N, Min AD,. Accuracy and significance of computed tomographic scan assessment of hepatic volume in patients undergoing liver transplantation. Transplantation 2000; 69: 545.
40. Van Thiel DH, Hagler NG, Schade RR, et al,. In vivo hepatic volume determination using sonography and computed tomography. Validation and a comparison of the two techniques. Gastroenterology 1985; 88: 1812.